Regeneron registers prostate cancer bispecific trial; posts REGN5381 heart failure resultsSep 30Weekly roundup, 4 itemsamrecibartcenvacibartUpdated
Regeneron registers Phase 1b trial of Factor XI/XII antibodies in dialysis patientsAug 12Trial updateamrecibartcenvacibart
Regeneron reports Q2 2026 results, cemdisiran filings accepted, fianlimab trial missesJul 30Quarterly updatecemdisiranfianlimab
Regeneron registers Phase 3 PICC clot-prevention trial; Sanofi runs sarilumab study as collaboratorJul 17Weekly roundup, 3 itemsamrecibartcenvacibart
Sign inSign in